The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
Open accessAbstract
OBJECTIVES: To assess whether a double therapy combination consisting of diuretics, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-steroidal anti-inflammatory drugs (NSAIDs) and the triple therapy combination of two of the aforementioned antihypertensive drugs to which NSAIDs are added are associated with an increased risk of acute kidney injury. DESIGN: Retrospective cohort study using nested case-control analysis. SETTING: General practices contributing data to the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. PARTICIPANTS: A cohort of 487,372 users of antihypertensive drugs. MAIN OUTCOME MEASURES: Rate ratios with 95% confidence intervals of acute kidney injury associated with current use of double and triple therapy combinations of antihypertensive drugs with NSAIDs. RESULTS: During a mean follow-up of 5.9 (SD 3.4) years, 2215 cases of acute kidney injury were identified (incidence rate 7/10,000 person years). Overall, current use of a double therapy combination containing either diuretics or angiotensin converting enzyme inhibitors or angiotensin receptor blockers with NSAIDs was not associated with an increased rate of acute kidney injury. In contrast, current use of a triple therapy combination was associated with an increased rate of acute kidney injury (rate ratio 1.31, 95% confidence interval 1.12 to 1.53). In secondary analyses, the highest risk was observed in the first 30 days of use (rate ratio 1.82, 1.35 to 2.46). CONCLUSIONS: A triple therapy combination consisting of diuretics with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and NSAIDs was associated with an increased risk of acute kidney injury. The risk was greatest at the start of treatment. Although antihypertensive drugs have cardiovascular benefits, vigilance may be warranted when they are used concurrently with NSAIDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Estimating measures of interaction on an additive scale for preventive exposures
Knol, M. J., VanderWeele, T. J., Groenwold, R. H. H., Klungel, O. H., Rovers, M. M., & Grobbee, D. E. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9554-9 · Cited by 776
Validity of diagnostic coding within the General Practice Research Database: a systematic review
Khan, N. F., Harrison, S. E., & Rose, P. W. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x483562 · Cited by 685
Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637
Nephropathy in Patients with Type 2 Diabetes
Remuzzi, G., Schieppati, A., & Ruggenenti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 587
Community-based incidence of acute renal failure
Hsu, C.-Y., McCulloch, C. E., Fan, D., Ordoñez, J. D., Chertow, G. M., & Go, A. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002297 · Cited by 570
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease
Lo, L. J., Go, A. S., Chertow, G. M., McCulloch, C. E., Fan, D., Ordoñez, J. D., & Hsu, C.-Y. (2009) · Kidney International · doi:10.1038/ki.2009.289 · Cited by 567
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients: A National Survey
Liangos, O., Wald, R., O’Bell, J. W., Price, L., Pereira, B. J., & Jaber, B. L. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00220605 · Cited by 528
Confounding by Indication: An Example of Variation in the Use of Epidemiologic Terminology
Salas, M., Hotman, A., & Stricker, B. H. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009758 · Cited by 471
Statistics in Epidemiology: The Case-Control Study
Breslow, N. E. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476660 · Cited by 463
Waikar, S. S., Wald, R., Chertow, G. M., Curhan, G. C., Winkelmayer, W. C., Liangos, O., Sosa, M.-A., & Jaber, B. L. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010073 · Cited by 460
Nonrecovery of Kidney Function and Death after Acute on Chronic Renal Failure
Hsu, C.-Y., Chertow, G. M., McCulloch, C. E., Fan, D., Ordon[Combining Tilde]ez, J. D., & Go, A. S. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05571008 · Cited by 396
Risk factors and outcome of hospital-acquired acute renal failure
Shusterman, N., Strom, B. L., Murray, T. G., Morrison, G., West, S. L., & Maislin, G. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90498-0 · Cited by 367
Estimating the financial cost of chronic kidney disease to the NHS in England
Kerr, M., Bray, B., Medcalf, J., O'Donoghue, D. J., & Matthews, B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs269 · Cited by 362
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population
Huerta, C., Castellsague, J., Varas-Lorenzo, C., & García Rodríguez, L. A. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.12.005 · Cited by 337
Drug-induced acute kidney injury
Schetz, M., Dasta, J., Goldstein, S., & Golper, T. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000184300.68383.95 · Cited by 313
Schneider, V., Lévesque, L. E., Zhang, B., Hutchinson, T., & Brophy, J. M. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj331 · Cited by 270
Validity of Administrative Database Coding for Kidney Disease: A Systematic Review
Vlasschaert, M. E. O., Bejaimal, S. A. D., Hackam, D. G., Quinn, R., Cuerden, M. S., Oliver, M. J., Iansavichus, A., Sultan, N., Mills, A., & Garg, A. X. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.08.031 · Cited by 220
Immeasurable Time Bias in Observational Studies of Drug Effects on Mortality
Suissa, S. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn135 · Cited by 191
Self-citationGislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Schramm, T. K., Hansen, M. L., Buch, P., Sørensen, R., Folke, F., Gadsbøll, N., Rasmussen, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.669101 · Cited by 183
Suissa, S., & Garbe, E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0652 · Cited by 179
Self-citationDrug combinations and impaired renal function – the ‘triple whammy’
Loboz, K. K., & Shenfield, G. M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.0306-5251.2004.2188.x · Cited by 178
Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs
Hernández-Dı́az, S., & Garcı́a-Rodrı́guez, L. A. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00682-3 · Cited by 176
Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009
Wu, T.-Y., Jen, M.-H., Bottle, A., Molokhia, M., Aylin, P., Bell, D., & Majeed, A. (2010) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2010.100113 · Cited by 164
Nonsteroidal Anti-inflammatory Drugs and the Risk of Hospitalization for Acute Renal Failure
Perez‐Gutthann, S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440200041005 · Cited by 163
Diuretics, ACE inhibitors and NSAIDs — the triple whammy
Thomas, M. C. (2000) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb125548.x · Cited by 158
Physiology of Renal Sodium Transport
Greger, R. (2000) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40679-2 · Cited by 158
Minimizing Bias Due to Confounding by Indication in Comparative Effectiveness Research
Psaty, B. M., & Siscovick, D. S. (2010) · JAMA · doi:10.1001/jama.2010.1205 · Cited by 146
Lafrance, J., & Miller, D. R. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1798 · Cited by 119
Risk of acute renal failure in patients with Type 2 diabetes mellitus
Girman, C. J., Kou, T. D., Brodovicz, K. G., Alexander, C. M., O’Neill, E. A., Engel, S. S., Williams‐Herman, D., & Katz, L. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03498.x · Cited by 114
Using prescription claims data for drugs available over‐the‐counter (OTC)
Yood, M. U., Campbell, U. B., Rothman, K. J., Jick, S. S., Lang, J. M., Wells, K. E., Jick, H., & Johnson, C. C. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1454 · Cited by 102
Patients are dying of acute renal failure *
Kellum, J. A., & Angus, D. C. (2002) · Critical Care Medicine · doi:10.1097/00003246-200209000-00041 · Cited by 98
Acute renal failure of medical type in an elderly population
Baraldi, A. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.suppl_7.25 · Cited by 97
The epidemiology of drug-induced disorders: the kidney
Taber, S., & Pasko, D. A. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740330802410462 · Cited by 84
Adhiyaman, V., Asghar, M., Oke, A., White, A. D., & Shah, I. U. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401005 · Cited by 71
Epidemiology and Outcomes of Acute Renal Failure in Hospitalized Patients: A National Survey
Garrick, R. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70143-3 · Cited by 61
Ishiguro, C., Fujita, T., Omori, T., Fujii, Y., Mayama, T., & Sato, T. S. (2008) · Journal of Epidemiology · doi:10.2188/jea.je2007413 · Cited by 55
Peeking into the black box: New biomarkers for acute kidney injury
Thurman, J. M., & Parikh, C. R. (2008) · Kidney International · doi:10.1038/sj.ki.5002739 · Cited by 39
Exposure of the elderly to potential nephrotoxic drug combinations in Belgium
Smets, H. L., Haes, J. F. D., Swaef, A. D., Jorens, P. G., & Verpooten, G. A. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1641 · Cited by 24
LaCivita, C. L., Funkhouser, E. M., Miller, M. J., Ray, M. N., Saag, K. G., Kiefe, C. I., Cobaugh, D. J., & Allison, J. J. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09005 · Cited by 17
Knauf, H., Bailey, M. A., Hasenfuss, G. P., & Mutschler, E. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0190-3 · Cited by 10
Opportunities for minimization of confounding in observational research
Quartey, G., Feudjo-Tepie, M. A., Wang, J., & Kim, J. (2011) · Pharmaceutical Statistics · doi:10.1002/pst.528 · Cited by 9
Han, L., Kim, N. V., Brandt, C., & Allore, H. G. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.10.004 · Cited by 7
Cited by
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
16., O. B. O. T. A. D. Q. I. W., Chawla, L. S., Bellomo, R., Bihorac, A., Goldstein, S. L., Siew, E. D., Bagshaw, S. M., Bittleman, D., Cruz, D., Endre, Z., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.2 · Cited by 1,537
Global epidemiology and outcomes of acute kidney injury
Hoste, E. A. J., Kellum, J. A., Selby, N. M., Zarbock, A., Palevsky, P. M., Bagshaw, S. M., Goldstein, S. L., Cerdá, J., & Chawla, L. S. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0052-0 · Cited by 1,486
Kalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
Metadata
- Authors
- Lapi, F., Azoulay, L., Yin, H., Nessim, S. J., & Suissa, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2013-01-08
- Volume
- 346
- Issue
- jan08 12
- Pages
- e8525-e8525
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2136932375
- Cited by
- 393
- References
- 50
- FWCI
- 24.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.